Sequella, Inc.
9Patents
6Active
9Granted
37Portfolio score
Filing activity: May 19, 2003 → Jan 21, 2011 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7456222B2 | Anti tubercular drug: compositions and methods | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7842729B2 | Anti tubercular drug: compositions and methods | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7919234B2 | Methods and compositions for determining the pathogenic status of infectious agents | Chemistry; Metallurgy | 1 | Active |
| US8501400B2 | Methods and compositions for determining the pathogenic status of infectious agents | Chemistry; Metallurgy | 1 | Active |
| US8202910B2 | Compositions and methods for treatment of infectious disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US7884097B2 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | Emerging Cross-Sectional Technologies | 0 | Active |
| US8198303B2 | Methods of use and compositions for the diagnosis and treatment of infectious diseases | Human Necessities | 0 | Active |
| US8268894B2 | Compositions and methods for the treatment of infectious diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US7652039B2 | Methods of use and compositions for the diagnosis and treatment of infectious disease | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.